Japan’s $1.7 Trillion Pension Giant Breaks Record, Returns 25% in 2020

Red hot equities help the world’s largest pension fund rake in $339 billion in investment gains.


Japan’s Government Pension Investment Fund (GPIF) reported a record 25% return on its investments, or 37.8 trillion yen (US$339 billion), for the fiscal year ended March 31, raising its total asset value to 186.16 trillion yen, or approximately $1.68 trillion. Its returns marked a record for the fund dating back to its inception in 2001. 

The robust returns were buoyed by the portfolio’s foreign and domestic equities, which gained 59.42% and 41.55%, respectively, for the year. Foreign bonds returned 7.06% for 2020, while domestic bonds were a drag on the fund, losing 0.68% during the year. 

For the fourth quarter of 2020, the fund’s portfolio returned 5.65%, or approximately 10.04 trillion yen. And like the full-year 2020 results, the strong return was led by foreign and domestic equities, which returned 12.04% and 9.26%, respectively, for the quarter.  

The performance is all the more impressive considering that more than a quarter (25.92%) of the portfolio is invested in underperforming domestic bonds, though the results benefited from the fund managers reducing the allocation to the asset class from 35% last year. The 10% was shifted into better-performing foreign bonds. Foreign equities account for 24.89% of the assets, while foreign bonds and domestic equities make up 24.61% and 24.58%, respectively. It uses mainly passive exchange-traded fund (ETF) strategies that reflect the markets.

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

The fund also allocates 5.7 trillion yen, which is the equivalent of more than $51.4 billion or approximately 3% of the portfolio, to environmental, social, and governance (ESG) indexes, and it owns approximately 440 billion yen in green, social, and sustainability bonds issued by multilateral banks including the World Bank.

Related Stories:

Japan’s GPIF Wants to Minimize the Drawbacks of Investing in Alts

Japan’s Government Pension Investment Fund Returns 3.05% in Q2

Japanese Pension Fund Loses $77 Billion in Fiscal 2019

Tags: , , , , ,

GIC Invests $1 Billion into Grifols’ Plasma Business  

The funding buys the Singapore sovereign wealth fund a minority stake in the health care firm. 


Singapore sovereign wealth fund GIC is investing $1 billion into US plasma business Biomat USA, a subsidiary of the Spanish global health care company Grifols, that will buy the allocator a minority stake in the firm.  

Grifols will use the investment to pay down the firm’s obligations as it aggressively expands its plasma business in the US, the company said Thursday. At the end of the first quarter of this year, the firm had about $7.3 billion (6.2 billion) in net financial debt.  

“This transaction supports Grifols’ business model and our strategy in plasma collection, together with a solid innovation portfolio focused on disease management beyond the therapies based on plasma-derived medicines,” Grifols’ co-CEO Víctor Grífols Deu said in a statement.  

Grifols, which already manages nearly 300 plasma collection centers in the country, has been pushing deeper into the plasma business through acquisitions over the past year. Investor interest in plasma jumped during the pandemic, since any antibodies floating in the blood of patients who recovered from the coronavirus can be used to treat those who are fighting the disease.  

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

Grifols expects demand for plasma medicines and therapies will only grow. This year, Grifols is planning on opening up to 20 new plasma centers. This is in addition to moves it made in April, when Grifols acquired seven plasma centers in a $55 million transaction from biopharma firm Kedrion. In March, Grifols bought 25 plasma donation centers from BPL Plasma in a $370 million transaction.  

In March, Grifols also finished acquiring biopharmaceutical company GigaGen in an $80 million transaction that will support the firm’s research and development of vaccines, including those for the coronavirus. The firm has been encouraging patients who have recovered from the coronavirus to give plasma.  

“With robust demand for Grifols’ plasma proteins, our efforts remain centered on doing our best to respond to the needs of patients and health care professionals,” Deu added.   

Health care and life science properties are promising sectors for investors such as GIC, which may be looking for returns that are also recession-proof. As far as real estate properties go, life sciences assets are particularly resilient to economic downturns. Tenants may leave other properties, like offices during the pandemic, but workers are unable to easily leave specialized laboratories with custom interiors.  

Still, capitalizing on the opportunity requires highly knowledgeable investment managers who understand the sophisticated assets. 

Related Stories:  

GIC and Equinix to Pump Extra $3.9 Billion into Data Centers 

Locus Raises $50 Million in Funding Round Led by GIC 

Stone Point, GIC to Acquire Recordkeeper Ascensus 

Tags: , , , , , , , , , , , ,

«